Christopher O'Brien, MD
3 clinical trials · Sponsor
◉ Watch Christopher O'Brien, MD
| Record | Firm | Date |
|---|---|---|
| Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies (NCT03593421) | Christopher O'Brien, MD | 2019-02-01 |
| Phase II AutoImmune Hepatitis (NCT03593460) | Christopher O'Brien, MD | 2019-01-01 |
| sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS (NCT02239562) | Christopher O'Brien, MD | 2014-11-14 |
Track Christopher O'Brien, MD automatically
Every clearance here is in the API, with alerts when new ones post.